The effect of different TP53 mutations on the chromosomal stability of a human colonic adenoma derived cell line with endogenous wild type TP53 activity, before and after DNA damage

Genes Chromosomes and Cancer

Volumn 20, Issue 1, 1997, Pages 44-52

  Williams, Ann C ^a   Miller, Jayne C ^a   Collard, Tracey ^a   Browne, Sara J ^a   Newbold, Robert F ^b   Paraskeva, Christos ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b BRUNEL UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA;

ARTICLE; CELL SURVIVAL; COLON ADENOMA; CONTROLLED STUDY; DNA DAMAGE; GAMMA IRRADIATION; GENE ACTIVITY; GENE MUTATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RADIOSENSITIVITY; TUMOR SUPPRESSOR GENE;

ADENOMA; CARCINOGENICITY TESTS; CELL SURVIVAL; CHROMOSOMES; COLONIC NEOPLASMS; DNA DAMAGE; GENES, P53; HUMANS; MUTATION; RADIATION DOSAGE; TELOMERASE; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 0030884437     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199709)20:1<44::AID-GCC7>3.0.CO;2-9     Document Type: Article

References (57)

1. Auer GU, Heselmeyer KM, Steinbeck RG, Munckwikland E, Zetterberg AD (1994) The relationship between aneuploidy and p53 overexpression during genesis of colorectal adenocarcinoma. Virchows Archiv 424:343-347.
2. Augenlicht LH, Richards C, Corner G, Pretlow TP (1996) Evidence for genomic instability in human colonic aberrant crypt foci. Oncogene 12:1767-1772.
3. Barrett MT, Galipeau PC, Sanchez CA, Emond MJ, Reid BJ (1996) Determination of the frequency of loss of heterozygosity in esophageal adenocarcinoma by cell sorting, whole genome amplification and microsatellite polymorphisms. Oncogene 12:1873-1878.
4. Bocker T, Schlegel J, Kullmann F, Stumm G, Zirngibl H, Epplen JT, Ruschoff J (1996) Genomic instability in colorectal carcinomas: Comparison of different evaluation methods and their biological significance. J Pathol 179:15-19.
5. Bouffler SD, Kemp CJ, Balmain A, Cox R (1995) Spontaneous and ionizing radiation-induced Chromosomal abnormalities in p53-deficient mice. Cancer Res 55:3883-3889.
6. Bracey TS, Miller JC, Preece A, Paraskeva C (1995) Gamma-radiation-induced apoptosis in human colorectal adenoma and carcinoma cell lines can occur in the absence of wild type p53. Oncogene 10:2391-2396.
7. Brachman DG, Beckett M, Graves D, Haraf D, Vokes E, Weichselhaum RR (1993) p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines. Cancer Res 53:3667-3669.
8. Campomenosi P, Ottaggio L, Moro F, Urbibi S, Bogliolo M, Zunino A, Camoriano A, Inga A, Gentile SL, Pellegata NS, Bonassi S, Bruzzone E, Iannone R, Pusani R, Menichini P, Ranzani GN, Bonatti S, Abbondandolo A, Fronza G (1996) Study on aneuploidy and p53 mutations in astrocytomas. Cancer Genet Cytogenet 88:95-102.
9. Donehower LA, Godley LA, Aldaz CM, Pyle R, Shi YP, Pinkel D, Gray T, Bradley A, Medina D, Varmus HE (1995) Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability. Gene Develop 9:882-895.
10. Dutta A, Ruppert JM, Aster JC, Winchester E (1993) Inhibition of DNA Replication Factor RPA by p53. Nature 365:79-82.
11. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
12. Fan S, El-Deiry WS, Bae I, Freeman J, Jondle D, Bhatia K, Fornace AJ, Magrath I, Kohn KW, O'Connor PM (1994) p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA-damaging agents. Cancer Res 54:5824-5830.
13. Fan S, Smith ML, Rivet DJ, Duba D, Zhan Q, Kohn KW, Fornace AJ, O'Connor PM (1995) Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifyline. Cancer Res 55:1649-1654.
14. Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61:759-767.
15. Galipeau PC, Cowan DS, Sanchez CA, Barrett MT, Emond MJ, Levine DS, Rabinovitch PS, Reid BJ (1996) 17p (p53) allelic losses 4N (G2/tetraploid) populations, and progression to aneuploidy in barretts esophagus. Gastroenterology 110:A515.
16. Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW, Giaccia AJ (1996) Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379:88-91.
17. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ (1993) The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816.
18. Havre PA, Yuan J, Hedriek L, Cho KR, Glazer PM (1995) p53 inactivation by HPV16 E6 results in increased mutagenesis in human cells. Cancer Res 55:4420-4424.
19. Hawkins DS, Demers GW, Galloway DA (1996) Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents. Cancer Res 56:892-898.
20. Huang LC, Clarkin KC, Wahl GM (1996) Sensitivity and selectivity of the DNA damage sensor responsible for activating p53-dependent G1 arrest. Proc Nat Acad Sci USA 93:4827-1832.
21. Joiner MC (1994) Evidence for induced radioresistance from survival and other end points: An Introduction. Radiat Res 138:S5-S8.
22. Kadhim MA, Lorimore SA, Townsend KMS, Goodhead DT, Buckle VJ, Wright EG (1995) Radiation-induced genomic instability. Delayed cytogenetic aberrations and apoptosis in primary human bone marrow cells, Int J Radiat Biol 67:287-293.
23. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51:6304-6311.
24. Kern SE, Pietenpol JA, Thiagalingam S, Seymour A, Kinzler KW, Vogelstein B (1992) Oncogenic forms of p53 inhibit p53-regulated gene expression. Science 256:827-830.
25. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, Coviello GM, Wright WE, Weinrich SL, Shay JW (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011-2015.
26. Kuerbitz, SJ, Plunkett BS, Walsh WV, Kastan MB (1992) Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci USA 89:7491-7495.
27. Lane DP (1992) p53, Guardian of the genome. Nature 358:15-16.
28. Levine AJ, Perry ME, Chang A, Silver A, Dittmer D, Wu M, Welsh D (1994) The 1993 Walter Hubert Lecture: The role of the p53 tumour-suppressor gene in tumorigenesis. Br J Cancer 69:409-416.
29. Li R, Botchan MR (1993) The acidic transcriptional activation domains of VP16 and p53 bind the cellular replication protein-A and stimulate in vitro BPY-1 DNA replication. Cell 73:1207-1221.
30. Little JB (1994) Changing views of cellular radiosensitivity. Radiat Res 140:299-311.
31. Liu PK, Kraus E, Wu TA, Strong LC, Tainsky MA (1996) Analysis of genomic instability in Li-Fraumeni fibroblasts with germline p53 mutations. Oncogene 12:2267-2278.
32. Livingstone LR, White A, Sprouse J, Livanos E, Jacks T, Tisty TD (1992) Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70:923-935.
33. Lowe SW, Ruley HE, Jacks T, Housman DE (1993) p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74:957-967.
34. Lowe SW, Bodis S, McClatchey A, Remington L, Ruley HE, Fisher DE, Housman DE, Jacks T (1994) p53 status and the efficacy of cancer therapy in vivo. Science 266:807-810.
35. WAF1/CIP1 -/- human cancer cell. Cancer Res 56:2250-2255.
36. McIllwrath AJ, Vasey PA, Ross GM, Brown R (1994) Cell cycle arrests and radiosensitivity of human tumor cell lines: Dependence on wild-type p53 for radiosensitivity. Cancer Res 54:3718-3722.
37. Merritt AJ, Potten CS, Kemp CJ, Hickman JA, Balmain A, Lane DP, Hall PA (1994) The Role of p53 in Spontaneous and Radiation-Induced Apoptosis in the Gastrointestinal Tract of Normal and p53- Deficient Mice. Cancer Res 54:614-617.
38. Modrich P (1991) Mechanisms and biological effects of mismatch repair. Annu Rev Genet 25:229-253.
39. Morgan WF, Murnane JP (1995) A role for genomic instability in cellular radioresistance? Cancer Metastasis Rev 14:49-58.
40. O'Connor PM, Jackman J, Jondle D, Bhatia K, Magrath I, Kohn KW (1993) Role ot the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitts lymphoma cell lines. Cancer Res 55:4776-1780.
41. Piatyszek MA, Kim NW, Weinrich SL, Hiyama K, Hiyama E, Wright WE, Shay JW (1995) Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP). Methods Cell Sci 17:1-15.
42. Powell SN, Defrank JS, Connell P, Eogan M, Preffer F, Dombkowski D, Tang W, Friend S (1995) Differential sensitivity of p53(-) and p53(+) cells to caffeine-induced radiosensitization and override of G(2) delay. Cancer Res 55:1643-1648.
43. Rolley N, Butcher S, Milner J (1995) Specific DNA binding by different classes of human p53 mutants. Oncogene 11:763-770.
44. Russell SJ, Ye YW, Waber PG, Shuford M, Schold SC, Nisen PD (1995) p53 mutations. 06-alkylguanine DNA alkyltransferase activity, and sensitivity to procarbazine in human brain tumors. Cancer 75:1339-1342.
45. Sabatier L, Dutrillaux B, Martin MB (1992) Chromosomal instability. Nature 357:548.
46. Saltman D, Morgan R, Cleary ML, de Lange T (1993) Telomeric structure in cells with chromosome end association. Chromosoma 102:121-138.
47. Smith ML, Chen IT, Zhan QM, O'Connor PM, Fornace AJ (1995) Involvement of the p53 tumor suppressor in repair of u.v.-type DNA damage. Oncogene 10:1053-1059.
48. Sun NC, Chu, Ehy, Chang CC (1973) Chromosome Newsletter 14:26.
49. Tainsky MA, Bischoff FZ, Strong LC (1995) Genomic instability due to germline p53 mutations drives preneoplastic progression toward cancer in human cells. Cancer Metastasis Rev 14:43-48.
50. Waldman T, Lengauer C, Kinzler KW, Vogelstein B (1996) Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 381:713-716.
51. Wang XW, Yeh H, Schaeffer L, Roy R, Moncollin V, Egly JM, Wang Z, Friedberg EC, Evans MK, Taffe BG, Bohr VA, Weeda G, Hoeijmakers JHJ, Forrester K, Harris CC (1995) p53 modulation of TFIIH-associatcd nucleotide excision repair activity. Nat Genet 10:188-195.
52. Wilcock D, Lane DP (1991) Localization of p53, retinoblastoma and host replication proteins at sites of viral replication in herpes infected cells. Nature 349:429-431.
53. Williams AC, Harper SJ, Paraskeva C (1990) Neoplastic transformation of a human colonic epithelial cell line: In vitro evidence for the adenoma to carcinoma sequence. Cancer Res 50:472-4730.
54. Williams AC, Browne SJ, Manning AM, Daffada P, Collard TJ, Paraskeva C (1994) Transfection and expression of mutant p53 protein does not alter the in vivo or in vitro growth characteristics of the AA/C1 human adenoma derived cell line, including sensitivity to transforming growth factor-beta 1. Oncogene 9:1479-1485.
55. Williams AC, Miller JC, Collard TJ, Bracey TS, Cosulich S, Paraskeva C (1995) Mutant p53 is not fully dominant over endogenous wild type p53 in a colorectal adenoma cell line as demonstrated by induction of MDM2 protein and retention of a p53 dependent G1 arrest after gamma irradiation. Oncogene 10:1-9.
56. Xia F, Wang X, Wang YH, Tsang NM, Yandell DW, Kelsey KT, Liber HL (1995) Altered p53 status correlates with differences in sensitivity to radiation-induced mutation and apoptosis in two closely related human lymphoblast lines. Cancer Res 55:12-15.
57. Xiong Y, Zhang H, Beach D (1993) Subimit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Gene Dev 7:1572-1583.